Sign In
Buy THTX
$3.39
+0 (+0%)
At Close: Dec 24, 2025
Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024
07:30am, Wednesday, 10'th Jul 2024
MONTREAL, July 10, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and c
Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update
07:30am, Wednesday, 26'th Jun 2024
MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and c
Theratechnologies (THTX) Is Attractively Priced Despite Fast-paced Momentum
09:51am, Wednesday, 05'th Jun 2024
Theratechnologies (THTX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are st
MONTREAL, May 23, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and co
Theratechnologies Reports on its Annual Meeting of Shareholders
04:30pm, Thursday, 09'th May 2024
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and co
MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and co
Theratechnologies (THTX) Upgraded to Buy: What Does It Mean for the Stock?
01:00pm, Tuesday, 23'rd Apr 2024
Theratechnologies (THTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
04:15pm, Monday, 15'th Apr 2024
MONTREAL, April 15, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
07:30am, Thursday, 11'th Apr 2024
MONTREAL, April 11, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies Inc. (THTX) Q1 2024 Earnings Call Transcript
10:47am, Wednesday, 10'th Apr 2024
Theratechnologies Inc. (NASDAQ:THTX ) Q1 2024 Earnings Conference Call April 10, 2024 8:30 AM ET Company Participants Julie Schneiderman - Senior Director, Communications & Corporate Affairs Paul Leve
Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024
07:30am, Wednesday, 10'th Apr 2024
MONTREAL, April 10, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
MONTREAL, April 08, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies Appoints Elina Tea to its Board of Directors
11:00am, Friday, 05'th Apr 2024
MONTREAL, April 05, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update
07:30am, Wednesday, 03'rd Apr 2024
MONTREAL, April 03, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform
07:30am, Thursday, 28'th Mar 2024
MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
